TENAX THERAPEUTICS, INC.
Clinical-stage pharma developing novel therapies for cardiovascular and pulmonary diseases.
TENX | US
Overview
Corporate Details
- ISIN(s):
- US88032L2097
- LEI:
- Country:
- United States of America
- Address:
- 101 GLEN LENNOX DRIVE, 27517 CHAPEL HILL
- Website:
- http://www.tenaxthera.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Tenax Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company focused on the development and commercialization of novel therapies for cardiovascular and pulmonary diseases with high unmet medical needs. The company's lead drug candidate is TNX-103, an oral formulation of levosimendan, which is being advanced through late-stage clinical trials for conditions such as pulmonary hypertension. Tenax's strategy centers on leveraging clinical insights and the established safety profiles of existing compounds to create innovative treatments and de-risk the development pathway.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all TENAX THERAPEUTICS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for TENAX THERAPEUTICS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for TENAX THERAPEUTICS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
